Product NewsBioAlliance Pharma annonce les résultats préliminaires de l’essai clinique de Phase I/II de doxorubicine Transdrug® pour le traitement du cancer primitif du foie
Product NewsUS Phase III study of Avastin in advanced pancreatic cancer does not meet primary endpoint
Product NewsOXFORD BIOMEDICA RECEIVES NOTICE OF ALLOWANCE FOR KEY US PATENT COVERING PARKINSON’S DISEASE PRODUCT, PROSAVIN®
Product NewsDe nouvelles données montrent que MabThera inhibe l'atteinte articulaire chez les patients souffrant de polyarthrite rhumatoïde
Product NewsDOMANTIS GRANTED BROAD EUROPEAN PATENT RIGHTS TO PIONEERING HALF-LIFE EXTENSION TECHNOLOGY
Product NewsReprise prochaine du recrutement dans l'étude internationale de phase III AVANT sur le traitement adjuvant postopératoire du cancer du côlon
Product NewsCeNeS strengthens the patent portfolio for its lead clinical programme M6G (morphine-6-glucuronide)
Product NewsMorphoSys and OncoMed Pharmaceuticals Sign Agreement for Use of HuCAL GOLD® in Cancer Research
Product NewsDe nouvelles données montrent qu'Herceptin entraîne un bénéfice remarquable en termes de survie lors de cancer du sein HER2-positif au stade précoce
Product NewsEMEA, the European Medicines Agency, recommends that the EU Commission should grant TopoTarget European marketing authorisation for Savene™
Product NewsAstro Instrumentation, LLC and Immunicon Corporation Team Up to Provide Automated Breakthrough System for Cancer Detection
Product NewsMorphoSys' Antibodies by Design Establishes Antibody Series in Partnership with Japanese Kazusa DNA Research Institute
Product NewsFirst European Product Containing Delta Biotechnology’s Recombumin® Receives Marketing Approval from the EMEA
Product NewsEXONHIT DEPOSE UN BREVET SUR UN PANEL DE GENES POUR LE DIAGNOSTIC SANGUIN DE LA MALADIE D’ALZHEIMER
Product NewsBioProgress announces the OTC launch of sore throat treatment, Collunovar for Dexo France
